Zisson Alex
Insider CIK 1512058 · OCRX Director, 10% owner · NONE Director · ASPX Director, 10% owner · CRXT Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CRXT Clarus Therapeutics Holdin | A Award | 2021-09-09 | 2021-09-13 | 490,531 | — | $0 | 490,531 | SEC↗ |
| CRXT Clarus Therapeutics Holdin | A Award | 2021-09-09 | 2021-09-13 | 2,470,756 | — | $0 | 5,692,381 | SEC↗ |
| CRXT Clarus Therapeutics Holdin | A Award | 2021-09-09 | 2021-09-13 | 2,731,094 | — | $0 | 3,221,625 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | U Tender | 2015-05-05 | 2015-05-06 | 4,835,731 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2015-01-28 | 2015-01-30 | 730,000 | $53.11 | $38.77M | 4,835,731 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | M Exercise deriv | 2015-01-08 | 2015-01-12 | 90,228 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | M Exercise deriv | 2015-01-08 | 2015-01-12 | 59,277 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | M Exercise deriv | 2015-01-08 | 2015-01-12 | 169,630 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | M Exercise | 2015-01-08 | 2015-01-12 | 319,135 | $3.88 | $1.24M | 5,589,739 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | D To issuer | 2015-01-08 | 2015-01-12 | 24,008 | $51.57 | $1.24M | 5,565,731 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | M Exercise deriv | 2014-10-09 | 2014-10-14 | 60,151 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | M Exercise | 2014-10-09 | 2014-10-14 | 60,151 | $3.88 | $233.4K | 5,280,375 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | D To issuer | 2014-10-09 | 2014-10-14 | 9,771 | $23.89 | $233.4K | 5,270,604 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | X Exercise deriv | 2014-05-14 | 2014-09-09 | 65,839 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | M Exercise deriv | 2014-05-14 | 2014-09-19 | 65,839 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | X Exercise | 2014-05-14 | 2014-09-09 | 65,839 | $3.88 | $255.5K | 5,232,624 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2014-05-14 | 2014-09-09 | 12,400 | $20.60 | $255.4K | 5,220,224 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | D To issuer | 2014-05-14 | 2014-09-19 | 12,400 | $20.60 | $255.4K | 5,220,224 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | M Exercise | 2014-05-14 | 2014-09-19 | 65,839 | $3.88 | $255.5K | 5,232,624 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | C Conversion deriv | 2014-02-10 | 2014-02-12 | 65,839 | — | $0 | 65,839 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | C Conversion deriv | 2014-02-10 | 2014-02-12 | 296,281 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | C Conversion deriv | 2014-02-10 | 2014-02-12 | 1,118,298 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | C Conversion deriv | 2014-02-10 | 2014-02-12 | 11,915,254 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | C Conversion deriv | 2014-02-10 | 2014-02-12 | 7,552,207 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | C Conversion deriv | 2014-02-10 | 2014-02-12 | 2,289,771 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | C Conversion deriv | 2014-02-10 | 2014-02-12 | 90,228 | — | $0 | 90,228 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | C Conversion deriv | 2014-02-10 | 2014-02-12 | 406,032 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | C Conversion deriv | 2014-02-10 | 2014-02-12 | 169,630 | — | $0 | 169,630 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | C Conversion deriv | 2014-02-10 | 2014-02-12 | 763,340 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | C Conversion deriv | 2014-02-10 | 2014-02-12 | 270,687 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | C Conversion deriv | 2014-02-10 | 2014-02-12 | 60,151 | — | $0 | 60,151 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | C Conversion deriv | 2014-02-10 | 2014-02-12 | 266,750 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | C Conversion deriv | 2014-02-10 | 2014-02-12 | 59,277 | — | $0 | 59,277 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | C Conversion | 2014-02-10 | 2014-02-12 | 5,083,451 | — | $0 | 5,083,451 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | P Buy | 2014-02-10 | 2014-02-12 | 83,334 | $12.00 | $1.00M | 5,166,785 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | J Other | 2013-07-15 | 2013-07-17 | 2,500,002 | $6.00 | $15.00M | 2,500,002 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | J Other | 2013-07-15 | 2013-07-17 | 1,675,677 | $6.00 | $10.05M | 1,675,677 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | J Other | 2013-07-15 | 2013-07-17 | 762,892 | $6.00 | $4.58M | 762,892 | SEC↗ |
| NONE Celator Pharmaceuticals In | A Award deriv | 2013-06-03 | 2013-06-04 | 28,000 | — | $0 | 28,000 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2012-10-01 | 2013-07-17 | 161,855 | $44.23 | $7.16M | 161,855 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2012-08-07 | 2013-07-17 | 31,835 | — | $0 | 31,835 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2012-08-07 | 2013-07-17 | 31,835 | — | $0 | 31,835 | SEC↗ |
| TZYM TRANZYME INC | A Award deriv | 2012-08-07 | 2012-08-09 | 31,835 | — | $0 | 31,835 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2012-03-30 | 2013-07-17 | 161,855 | $44.23 | $7.16M | 161,855 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2011-04-19 | 2013-07-17 | 25,000 | — | $0 | 25,000 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2011-04-19 | 2013-07-17 | 25,000 | — | $0 | 25,000 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2010-02-11 | 2013-07-17 | 25,000 | — | $0 | 25,000 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2009-02-11 | 2013-07-17 | 25,000 | — | $0 | 25,000 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2006-02-06 | 2013-07-17 | 100,000 | — | $0 | 100,000 | SEC↗ |